Åström Håkan, Blomgren Lena
Läkarstudent, Universitetssjukhuset Örebro, fakulteten för medicin och hälsa.
överläkare, docent, Venöst centrum Karlskoga; kärl-toraxkliniken, Universitetssjukhuset Örebro, fakulteten för medicin och hälsa.
Lakartidningen. 2021 May 24;118:20218.
The aim of this study was to estimate the number of treatments for varicose veins (VV) performed in Sweden annually and the proportion of these unknown to the National Board of Health and Welfare or to the Swedish National Registry for Vascular Surgery, Swedvasc. Aggregated data was collected from the National Patient Registry (NPR), Swedvasc and inquiries sent to hospitals and private clinics for the years 2016-2018, the calculated volumes from these three sources were comparable with extrapolated volumes obtained from a coverage control between NPR and Swedvasc for treatments of the great saphenous vein. The approximated volumes of VV interventions annually were 8 650, 10 750 and 12 250, the proportion not registered in NPR 29%, 51% and 58% respectively, the corresponding figures for Swedvasc 56%, 33% and 20%. Interventions for VV are thus underreported in Sweden and this has implications for allocation of resources and quality control.
本研究的目的是估算瑞典每年进行的静脉曲张（VV）治疗次数，以及这些治疗中未被国家卫生与福利委员会或瑞典国家血管外科注册中心（Swedvasc）记录的比例。收集了2016 - 2018年期间来自国家患者注册中心（NPR）、Swedvasc的数据以及向医院和私人诊所发出的问询信息，这三个来源计算出的治疗量与通过NPR和Swedvasc之间大隐静脉治疗覆盖率对照得出的外推治疗量相当。每年VV干预的大致治疗量分别为8650、10750和12250，未在NPR中登记的比例分别为29%、51%和58%，在Swedvasc中的相应比例分别为56%、33%和20%。因此，瑞典对VV干预的报告不足，这对资源分配和质量控制有影响。
